Denver, CO, September 19, 2014 --(PR.com
)-- Colorado BioScience Association (CBSA) congratulates the four Colorado headquartered companies that presented at the inaugural White Hat Life Science Investor Conference held September 17 and 18 at the Grand Hyatt in Phoenix, AZ. The announcement is made by April Giles, CBSA President and CEO, who says, “We were excited to be a partner in the 2014 White Hat Life Science Investor Conference and to help showcase three of Colorado’s promising bioscience companies during the event.” The participating Colorado companies included EndoShape, Fluonic, ValveXchange and ViroCyt.
The conference, spearheaded by the Arizona BioIndustry Association (AZBio), was presented by the National Venture Capital Association and leading life science associations of the Rocky Mountain Southwest Region, including the CBSA. This conference is showcasing 34 of the region’s top life science companies to interested investors including business development professionals from large pharmaceutical, biotechnology, medical device and diagnostic companies.
“The Rocky Mountain and Southwest Regions have become increasingly recognized for their growth in the bioscience and heath care innovations. The White Hat Life Science Investor Conference served as another opportunity to highlight the work being done in Colorado and the surrounding region while at the same time bringing new potential partners and investors into our community,” Giles said.
Colorado bioscience companies selected to present in the 2014 White Hat Investor Conference:
* EndoShape, Inc., Boulder – EndoShape’s mission is to commercialize novel medical devices based on its proprietary polymer technology. EndoShape is focused on the coil embolization & occlusion market. EndoShape is currently commercializing the Medusa™ Vascular Plug which is FDA 510(k) cleared for sale in the United States. Visit, http://www.endoshape.com.
* Fluonic, Inc., Boulder - Fluonic is a privately held medical device company dedicated to making infusion drug delivery safer for patients through the development of a new generation of infusion devices and information systems, driven by a breakthrough MEMS flow sensor technology. Fluonic infusion products improve patients’ safety and compliance while improving medical staff productivity and reducing costs, which will set a new standard of care for the industry. Visit, http://fluonic.com.
* ValveXchange, Inc. – Greenwood Village – ValveXchange (VXi) is dedicated to improving the lives of patients requiring heart valve replacements. VXi is developing a two-piece bioprosthetic tissue valve system that resolves the long standing compromises between conventional mechanical and tissue-based prosthetic valves. Unlike today’s transcatheter valves, the VXi technology is Without Compromise. The VXi exchangeable valve system is being designed to offer leaflet exchange, as well as the original implant, without open-heart surgery and without the safety and longevity compromises of transcatheter approaches. Visit: http://www.valvexchange.com.
* ViroCyt, LLC, Boulder - ViroCyt, LLC was created in late 2012 to focus on the commercialization of novel technologies that enable rapid quantification of viruses, such as the Virus Counter® 3100. The Company’s mission is to provide the tools that deliver meaningful improvements to critical biotechnology processes such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role. Visit, http://www.virocyt.com.
For a complete listing of presenting companies, visit the conference website at http://www.azbio.org/white-hat-investors-2014.
About Arizona BioIndustry Association
AZBio is a not-for-profit, 501(c)(6) trade association that seeks to unify, empower and advance its member organizations, allowing them to benefit individually by acting collectively. AZBio strives to enhance the environment that makes Arizona a place where bioscience companies can grow and succeed. AZBio is the state affiliate in Arizona for the Biotechnology Industry Organization (BIO), the preeminent trade association for the biotechnology industry in the United States. For more information, visit http://www.azbio.org.
About Colorado BioScience Association
CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.
CBSA also is found on these social media sites:
LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation
Brittany Callahan, Marketing & Membership Manager, Colorado BioScience Association - http://www.cobioscience.com – 720-382-5918, email@example.com
Joan Koerber-Walker, President and CEO, Arizona Bioindustry Association - http://www.azbio.org - 480-332-9636, firstname.lastname@example.org
Maggie Chamberlin Holben, APR, Absolutely Public Relations - http://www.absolutelypr.com - 303-984-9801, email@example.com